SM-08 NEURO-ONCOLOGICAL PATIENTS ADMITTED IN INTENSIVE-CARE UNIT (ICU): PATIENT'S CHARACTERISTICS, PREDICTIVE FACTORS OF DEATH IN ICU AND FUNCTIONAL OUTCOME

Por Tabouret, Emeline, Boucard, Celine, Barrie, Maryline, Autran, Didier, Bruder, Nicolas, Chinot, Olivier
Publicado no Neuro Oncol (2014)

Association of carcinoid tumor and low grade glioma

Por Tabouret, Emeline, Barrié, Maryline, Vicier, Cecile, Gonçalves, Anthony, Chinot, Olivier, Viens, Patrice, Madroszyk, Anne
Publicado em 2012

MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma

Por Tabouret, Emeline, Boudouresque, Françoise, Farina, Patrizia, Barrié, Maryline, Bequet, Céline, Sanson, Marc, Chinot, Olivier
Publicado no Neuro Oncol (2015)

ASSOCIATION OF MATRIX METALLOPROTEINASE 2 (MMP2) BASELINE PLASMA LEVEL WITH RESPONSE AND SURVIVAL AND CHANGE OVERTIME IN PATIENTS TREATED WITH BEVACIZUMAB FOR RECURRENT HIGH GRADE...

Por Chinot, Olivier-L, Boudouresque, Françoise, Barrie, Maryline, Matta, Mona, Boucard, Celine, Loundou, Anderson, Figarella-Branger, Dominique, Ouafik, L'Houcine, Tabouret, Emeline
Publicado em 2014

FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan

Por Colavolpe, Cécile, Chinot, Olivier, Metellus, Philippe, Mancini, Julien, Barrie, Maryline, Bequet-Boucard, Céline, Tabouret, Emeline, Mundler, Olivier, Figarella-Branger, Dominique, Guedj, Eric
Publicado em 2012

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma

Por Tabouret, Emeline, Boudouresque, Françoise, Barrie, Maryline, Matta, Mona, Boucard, Celine, Loundou, Anderson, Carpentier, Antoine, Sanson, Marc, Metellus, Philippe, Figarella-Branger, Dominique, Ouafik, L'Houcine, Chinot, Olivier
Publicado em 2014

AI-29 ANGIOGENIC SWITCH FROM VEGFR2/HIF1α IN NEWLY DIAGNOSED GLIOBLASTOMA (GB) TO CXCR4-SDF1 PATHWAY IN RECURRENT PAIRED TUMOR AFTER RADIOTHERAPY (RT)-TEMOZOLOMIDE (TMZ)

Por Tabouret, Emeline, Tchoghandjian, Aurelie, Denicolai, Emilie, Delfino, Christine, Metellus, Philippe, Padovani, Laetitia, Nanni, Isabelle, Barrie, Maryline, Boucard, Celine, Ouafik, L'Houcine, Figarella-Branger, Dominique, Chinot, Olivier
Publicado em 2014

CN-18 RELATIONSHIPS BETWEEN DOSE INTENSITY, TOXICITY, AND OUTCOME IN OLIGODENDROGLIAL TUMORS (OG) TREATED WITH PCV REGIMEN

Por Tabouret, Emeline, Reyes-Botero, German, Dehais, Caroline, Daros, Marine, Barrie, Maryline, Matta, Mona, Petrirena, Gregorio, Autran, Didier, Duran, Alberto, Boucard, Celine, Delattre, Jean Yves, Chinot, Olivier
Publicado em 2014

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

Por Carpentier, Alexandre, Metellus, Philippe, Ursu, Renata, Zohar, Sarah, Lafitte, Francois, Barrié, Maryline, Meng, Yuxia, Richard, Margaretha, Parizot, Christophe, Laigle-Donadey, Florence, Gorochov, Guy, Psimaras, Dimitri, Sanson, Marc, Tibi, Annick, Chinot, Olivier, Carpentier, Antoine F.
Publicado em 2010